Unenhanced MR angiography: Techniques and clinical applications in patients with chronic kidney disease

Radiographics

Volumn 31, Issue 2, 2011, Pages 13-33

  Morita, Satoru ^a   Masukawa, Ai ^a   Suzuki, Kazufumi ^a   Hirata, Masami ^a   Kojima, Shinya ^a   Ueno, Eiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CHRONIC KIDNEY FAILURE; HUMAN; IMAGE ENHANCEMENT; KIDNEY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; VASCULARIZATION;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; KIDNEY; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; PERIPHERAL ARTERIAL DISEASE;

EID: 79953780427     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.312105075     Document Type: Review

References (69)

1. Chi Y, Jaff M. Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv 2008;71 (4):475-89.
2. O'Hare A, Glidden D, Fox C, Hsu C. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004;109(3):320-323.
3. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17(7):2034-2047.
4. Go A, Chertow G, Fan D, McCulloch C, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-1305.
5. Prince M, Arnoldus C, Frisoli J. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6(1):162-166.
6. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer K, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 2002;17(5):824-828.
7. Bongartz G, Mayr M, Bilecen D. Magnetic resonance angiography (MRA) in renally impaired patients: when and how. Eur J Radiol 2008;66(2): 213-219.
8. Prince M, Narasimham D, Stanley J, et al. Breathhold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197(3):785-792.
9. Perriss R, Løkkegaard H, Løgager V, Chabanova E, Thomsen H. Preliminary experience with contrast-enhanced MR angiography in patients with end-stage renal failure. Acad Radiol 2005;12(5): 652-657.
10. Cowper S, Robin H, Steinberg S, Su L, Gupta S, LeBoit P. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356(9234):1000-1001.
11. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21(4):1104-1108.
12. Miyazaki M, Lee V. Nonenhanced MR angiography. Radiology 2008;248(1):20-43.
13. Kramer H, Quick H, Tombach B, Schoenberg S, Barkhausen J. Whole-body MRA. Eur Radiol 2008; 18(9):1925-1936.
14. Levey A, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139(2):137-147.
15. Committee ECMS. ESUR Guide Lines on Contrast Media, version 7.0. European Society of Urogenital Radiology; 2009 [11 November 2009]; Available at: http://www.esur.org/Contrast-media.46.0.html.
16. Kaufman J, McCarter D, Geller S, Waltman A. Twodimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls. AJR Am J Roentgenol 1998;171(1):129-135.
17. Tatli S, Lipton M, Davison B, Skorstad R, Yucel E. From the RSNA refresher courses: MR imaging of aortic and peripheral vascular disease. RadioGraphics 2003;23:S59-S78.
18. U-King-Im J, Young V, Gillard J. Carotid-artery imaging in the diagnosis and management of patients at risk of stroke. Lancet Neurol 2009;8(6):569-580.
19. Bitar R, Gladstone D, Sahlas D, Moody A. MR angiography of subclavian steal syndrome: pitfalls and solutions. AJR Am J Roentgenol 2004;183(6):1840-1841.
20. Nelemans P, Leiner T, de Vet H, van Engelshoven J. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217(1):105-114.
21. Ozsarlak O, Van Goethem J, Maes M, Parizel P. MR angiography of the intracranial vessels: technical aspects and clinical applications. Neuroradiology 2004;46(12):955-972.
22. Pui M. Cerebral MR venography. Clin Imaging 2004;28(2):85-89.
23. de Haan M, Kouwenhoven M, Thelissen R, et al. Renovascular disease in patients with hypertension: detection with systolic and diastolic gating in threedimensional, phase-contrast MR angiography. Radiology 1996;198(2):449-456.
24. Steffens J, Link J, Müller-Hülsbeck S, Freund M, Brinkmann G, Heller M. Cardiac-gated two-dimensional phase-contrast MR angiography of lower extremity occlusive disease. AJR Am J Roentgenol 1997;169(3):749-754.
25. Nghiem H, Winter T, Mountford M, et al. Evaluation of the portal venous system before liver transplantation: value of phase-contrast MR angiography. AJR Am J Roentgenol 1995;164(4):871-878.
26. Van Grimberge F, Dymarkowski S, Budts W, Bogaert J. Role of magnetic resonance in the diagnosis of subclavian steal syndrome. J Magn Reson Imaging 2000;12(2):339-342.
27. Vanninen R, Manninen H, Partanen P, Vainio P, Soimakallio S. Carotid artery stenosis: clinical efficacy of MR phase-contrast flow quantification as an adjunct to MR angiography. Radiology 1995;194(2):459-467.
28. Mohajer K, Zhang H, Gurell D, et al. Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurements. J Magn Reson Imaging 2006;23(3):355-360.
29. Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007;243(1):70-79.
30. Barger A, Block W, Toropov Y, Grist T, Mistretta C. Time-resolved contrast-enhanced imaging with isotropic resolution and broad coverage using an undersampled 3D projection trajectory. Magn Reson Med 2002;48(2):297-305.
31. Hope T, Markl M, Wigström L, Alley M, Miller D, Herfkens R. Comparison of flow patterns in ascending aortic aneurysms and volunteers using fourdimensional magnetic resonance velocity mapping. J Magn Reson Imaging 2007;26(6):1471-1479.
32. Frydrychowicz A, Winterer J, Zaitsev M, et al. Visualization of iliac and proximal femoral artery hemodynamics using time-resolved 3D phase contrast MRI at 3T. J Magn Reson Imaging 2007;25(5):1085-1092.
33. Yamashita S, Isoda H, Hirano M, et al. Visualization of hemodynamics in intracranial arteries using timeresolved three-dimensional phase-contrast MRI. J Magn Reson Imaging 2007;25(3):473-478.
34. Uribe S, Beerbaum P, Sørensen T, Rasmusson A, Razavi R, Schaeffter T. Four-dimensional (4D) flow of the whole heart and great vessels using real-time respiratory self-gating. Magn Reson Med 2009;62 (4):984-992.
35. Markl M, Draney M, Hope M, et al. Time-resolved 3-dimensional velocity mapping in the thoracic aorta: visualization of 3-directional blood flow patterns in healthy volunteers and patients. J Comput Assist Tomogr 2004;28(4):459-468.
36. Wedeen V, Meuli R, Edelman R, et al. Projective imaging of pulsatile flow with magnetic resonance. Science 1985;230(4728):946-948.
37. Lim R, Hecht E, Xu J, et al. 3D nongadoliniumenhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008;28(1):181-189.
38. Miyazaki M, Sugiura S, Tateishi F, Wada H, Kassai Y, Abe H. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 2000;12(5):776-783.
39. Lim R, Storey P, Atanasova I, et al. Three-dimensional electrocardiographically gated variable flip angle FSE imaging for MR angiography of the hands at 3.0 T: initial experience. Radiology 2009;252(3):874-881.
40. Urata J, Miyazaki M, Wada H, Nakaura T, Yamashita Y, Takahashi M. Clinical evaluation of aortic diseases using nonenhanced MRA with ECG-triggered 3D half-Fourier FSE. J Magn Reson Imaging 2001; 14(2):113-119.
41. Yamamoto A, Nakamura K, Miyazaki M, Shioya Y, Kawanami S, Matsufuji Y. Non-Contrast-Enhanced MRDSA of peripheral arteries using continuous acquisitions of ECG-triggered 2D half-Fourier FSE (abstr). In: Proceedings of the Thirteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2003; 1709.
42. Fuchs F, Laub G, Othomo K. TrueFISP-technical considerations and cardiovascular applications. Eur J Radiol 2003;46(1):28-32.
43. Scheffler K, Lehnhardt S. Principles and applications of balanced SSFP techniques. Eur Radiol 2003;13(11):2409-2418.
44. Wyttenbach R, Braghetti A, Wyss M, et al. Renal artery assessment with nonenhanced steady-state free precession versus contrast-enhanced MR angiography. Radiology 2007;245(1):186-195.
45. Shea S, Deshpande V, Chung Y, Li D. Three-dimensional true-FISP imaging of the coronary arteries: improved contrast with T2-preparation. J Magn Reson Imaging 2002;15(5):597-602.
46. Amano Y, Takahama K, Kumita S. Non-contrast-enhanced MR angiography of the thoracic aorta using cardiac and navigator-gated magnetization-prepared three-dimensional steady-state free precession. J Magn Reson Imaging 2008;27(3):504-509.
47. Krishnam M, Tomasian A, Malik S, Desphande V, Laub G, Ruehm S. Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases. Eur Radiol 2010;20(6):1311-1320.
48. Roditi G, Maki J, Oliveira G, Michaely H. Renovascular imaging in the NSF Era. J Magn Reson Imaging 2009;30(6):1323-1334.
49. Maki J, Wilson G, Eubank W, Glickerman D, Millan J, Hoogeveen R. Navigator-gated MR angiography of the renal arteries: a potential screening tool for renal artery stenosis. AJR Am J Roentgenol 2007;188(6):W540-W546.
50. Ishida M, Kato S, Sakuma H. Cardiac MRI in ischemic heart disease. Circ J 2009;73(9):1577-1588.
51. Kim W, Danias P, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345(26): 1863-1869.
52. Sakuma H, Ichikawa Y, Suzawa N, et al. Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography. Radiology 2005;237(1):316-321.
53. van Laar P, van der Grond J, Hendrikse J. Brain perfusion territory imaging: methods and clinical applications of selective arterial spin-labeling MR imaging. Radiology 2008;246(2):354-364.
54. Nishimura D, Macovski A, Pauly J, Conolly S. MR angiography by selective inversion recovery. Magn Reson Med 1987;4(2):193-202.
55. Spuentrup E, Manning W, Börnert P, Kissinger K, Botnar R, Stuber M. Renal arteries: navigator-gated balanced fast field-echo projection MR angiography with aortic spin labeling: initial experience. Radiology 2002;225(2):589-596.
56. Lanzman R, Voiculescu A, Walther C, et al. ECGgated nonenhanced 3D steady-state free precession MR angiography in assessment of transplant renal arteries: comparison with DSA. Radiology 2009;252 (3):914-921.
57. Shimada K, Isoda H, Okada T, et al. Non-contrastenhanced MR portography with time-spatial labeling inversion pulses: comparison of imaging with three-dimensional half-fourier fast spin-echo and true steady-state free-precession sequences. J Magn Reson Imaging 2009;29(5):1140-1146.
58. Satogami N, Okada T, Koyama T, Gotoh K, Kamae T, Togashi K. Visualization of external carotid artery and its branches: non-contrast-enhanced MR angiography using balanced steady-state free-precession sequence and a time-spatial labeling inversion pulse. J Magn Reson Imaging 2009;30(3):678-683.
59. Shimada K, Isoda H, Okada T, et al. Non-contrastenhanced MR angiography for selective visualization of the hepatic vein and inferior vena cava with true steady-state free-precession sequence and timespatial labeling inversion pulses: preliminary results. J Magn Reson Imaging 2009;29(2):474-479.
60. Shimada K, Isoda H, Okada T, et al. Non-contrastenhanced hepatic MR angiography with true steadystate free-precession and time spatial labeling inversion pulse: optimization of the technique and preliminary results. Eur J Radiol 2009;70(1):111-117.
61. van Osch M, Hendrikse J, Golay X, Bakker C, van der Grond J. Non-invasive visualization of collateral blood flow patterns of the circle of Willis by dynamic MR angiography. Med Image Anal 2006;10(1): 59-70.
62. Hori M, Shiraga N, Watanabe Y, et al. Time-resolved three-dimensional magnetic resonance digital subtraction angiography without contrast material in the brain: initial investigation. J Magn Reson Imaging 2009;30(1):214-218.
63. Stemerman D, Krinsky G, Lee V, Johnson G, Yang B, Rofsky N. Thoracic aorta: rapid black-blood MR imaging with half-Fourier rapid acquisition with relaxation enhancement with or without electrocardiographic triggering. Radiology 1999;213(1):185-191.
64. Yuan C, Mitsumori L, Beach K, Maravilla K. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001;221(2):285-299.
65. Song H, Wright A, Wolf R, Wehrli F. Multislice double inversion pulse sequence for efficient blackblood MRI. Magn Reson Med 2002;47(3):616-620.
66. Fayad Z, Fuster V, Fallon J, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102(5):506-510.
67. Ida M, Motoyoshi K, Fukuyama H, Yoshizawa H, Yorozu N, Hino K. Carotid Plaque Imaging with BLADE (abstr). In: Proceedings of the Thirteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2008; 3421.
68. Michaely H, Kramer H, Weckbach S, Dietrich O, Reiser M, Schoenberg S. Renal T2-weighted turbospin-echo imaging with BLADE at 3.0 Tesla: initial experience. J Magn Reson Imaging 2008;27(1): 148-153.
69. Mihai G, Chung Y, Kariisa M, Raman S, Simonetti O, Rajagopalan S. Initial feasibility of a multi-station high resolution three-dimensional dark blood angiography protocol for the assessment of peripheral arterial disease. J Magn Reson Imaging 2009;30(4): 785-793.